BJP

Certificate Shows Local UP BJP Leader Given 5 Doses of Covid Vaccine, 6th Scheduled; Probe Ordered

The vaccination certificate of a BJP booth level leader here incorrectly shows that he has been given five doses of the COVID-19 vaccine and is scheduled for the sixth, with…

View Post

RSS Chief Mohan Bhagwat Tests Covid-19 Positive, Hospitalized

Rashtriya Swayamsevak Sangh chief Mohan Bhagwat on Friday has tested positive for Covid-19. “He is admitted to a hospital in Nagpur”, the organization said. In a tweet by RSS in…

View Post

Latest News

BJP Old promises, new accents

By Manzoor-ul-Hassan Having already implemented the Ayushman Bharat scheme before, the Bharatiya Janata Party (BJP) did precious little except reiterate its commitment to reducing the burden of healthcare expenditure of…

View Post

Latest News

Congress manifesto smartly targets BJP on health reforms

The party devalues BJP’s Ayushman Bharat scheme with Universal Health Coverage and promises legislation for the Right to Health in India By Manzoor-ul-Hassan The Congress on Tuesday released its…

View Post

Menu

Certificate Shows Local UP BJP Leader Given 5 Doses of Covid Vaccine, 6th Scheduled; Probe Ordered

RSS Chief Mohan Bhagwat Tests Covid-19 Positive, Hospitalized

BJP Old promises, new accents

Congress manifesto smartly targets BJP on health reforms

Vinod Kambli Admitted To Hospital In Maharshtra, Condition Critical

Diabetes and Inflammation Linked to Accelerated Brain Aging and Higher Dementia Risk: Experts

Heart Muscle Regeneration Observed in Patients with Artificial Hearts, Study Finds

Flesh-Eating Ulcer Cases Surge in Australia: Health Authorities Issue Warning

Epigamia Co-Founder Rohan Mirchandani Passes Away at 42 Due to Cardiac Arrest: Key Risk Factors and Warning Signs for Men in Their 40s

Does the 2022 H5N1 Virus Bind and Replicate Better in the Human Respiratory Tract? Here’s The Truth

Walking Speed Is An Indicator of Metabolic Health in Obese Individuals: Study Reveals

First-Ever Blood-Stage Malaria Vaccine Shows Promising Results in Phase IIb Trial